Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Reata had issues with Bardoxolone and CV events in previous trials, so I believe 208 would be valued at least as highly if not a great deal more. All just my opinion and speculation, but RETA worth understanding in context of CKD valuations.
